We are live on
!
Find out more
AP
Antipodes Partners Portfolio holdings
AUM
$5.19B
1-Year Est. Return
36.17%
This Fund
S&P 500
This Quarter
Est. Return
+12.8%
1 Year Est. Return
+36.17%
3 Year Est. Return
+104%
5 Year Est. Return
+169.34%
10 Year Est. Return
–
AUM
$2.79B
AUM Growth
+$296M
(+12%)
Cap. Flow
+$60.2M
Cap. Flow
% of AUM
2.16%
Top 10 Holdings %
Top 10 Hldgs %
47.67%
Holding
72
New
28
Increased
18
Reduced
23
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halliburton
HAL
|
+$89.1M |
| 2 |
Fomento Económico Mexicano
FMX
|
+$73.4M |
| 3 |
Seagate
STX
|
+$59M |
| 4 |
PagSeguro Digital
PAGS
|
+$50.9M |
| 5 |
Itaú Unibanco
ITUB
|
+$43.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EQT Corp
EQT
|
+$103M |
| 2 |
Amazon
AMZN
|
+$87.6M |
| 3 |
Northrop Grumman
NOC
|
+$44.1M |
| 4 |
Trip.com Group
TCOM
|
+$44M |
| 5 |
Merck
MRK
|
+$41.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.63% |
| 2 | Technology | 18.54% |
| 3 | Communication Services | 15.07% |
| 4 | Materials | 9.18% |
| 5 | Industrials | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
GDS Holdings
GDS
$6.41B
| $72K | ﹤0.01% |
+3,506
| New | +$53.6K |
|
|
NEX
52
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $68K | ﹤0.01% |
+7,413
| New | +$72.5K |
|
53
Henry Schein
HSIC
$9.7B
| $65K | ﹤0.01% |
+815
| New | +$61.7K |
|
54
Virtu Financial
VIRT
$5.15B
| $57K | ﹤0.01% |
+2,821
| New | +$61.3K |
|
|
55
EQT Corp
EQT
$33B
| $52K | ﹤0.01% |
1,550
-2,560,099
| -100% | -$103M |
|
56
DoorDash
DASH
$86.1B
| $51K | ﹤0.01% |
+1,051
| New | +$54.6K |
|
57
Caesars Entertainment
CZR
$6.03B
| $43K | ﹤0.01% |
+1,056
| New | +$47K |
|
58
GXO Logistics
GXO
$5.8B
| $38K | ﹤0.01% |
+895
| New | +$35.9K |
|
59
argenx
ARGX
$54.6B
| $37K | ﹤0.01% |
+98
| New | +$36.7K |
|
60
Similarweb
SMWB
$632M
| $33K | ﹤0.01% |
+5,263
| New | +$30.1K |
|
61
Ryanair
RYAAY
$31.2B
| $32K | ﹤0.01% |
+1,098
| New | +$31.2K |
|
62
Alnylam Pharmaceuticals
ALNY
$27.5B
| $28K | ﹤0.01% |
+118
| New | +$25.2K |
|
63
Westlake Corp
WLK
$9.19B
| $26K | ﹤0.01% |
+261
| New | +$26.3K |
|
64
UiPath
PATH
$6.41B
| $24K | ﹤0.01% |
+1,935
| New | +$23.9K |
|
|
PGRU
65
DELISTED
PropertyGuru Group Limited
PGRU
| $20K | ﹤0.01% |
+4,791
| New | +$23.2K |
|
66
CF Industries
CF
$19.3B
| $16K | ﹤0.01% |
+193
| New | +$19.6K |
|
|
ACCD
67
DELISTED
Accolade Inc
ACCD
| $7K | ﹤0.01% |
+886
| New | +$8.46K |
|
|
AMED
68
DELISTED
Amedisys
AMED
| $6K | ﹤0.01% |
+77
| New | +$6.94K |
|
|
TELL
69
DELISTED
Tellurian Inc.
TELL
| $6K | ﹤0.01% |
+3,864
| New | +$9.68K |
|
|
70
Amazon
AMZN
$2.53T
| – | – |
-774,971
| Closed | -$87.6M |
|
71
Petrobras
PBR
$123B
| – | – |
-15,876
| Closed | -$195K |
|
72
Thermo Fisher Scientific
TMO
$214B
| – | – |
-5,381
| Closed | -$2.73M |
|
Similar funds
MS
AUB
KACA
DDC
MIM
AAI
SCM
SDIC
Antipodes Partners's Q4 2022 Portfolio in Review
As of Q4 2022, Antipodes Partners held 72 positions worth $2.79B, up 12% from $2.49B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Antipodes Partners's Q4 2022 filing shows 28 new, 18 increased, 23 reduced and 3 closed positions. Its largest new stake was Halliburton: 2,516,888 shares worth $99M. The largest sale was EQT Corp, an estimated $103M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 16% a quarter earlier, followed by Technology and Communication Services.
- Antipodes Partners's largest Q4 2022 buy was Halliburton: 2,516,888 shares worth $99M.
- Antipodes Partners added most to Fomento Económico Mexicano in Q4 2022, an estimated $73.4M increase.
- Antipodes Partners's biggest Q4 2022 reduction was EQT Corp, cutting an estimated $103M.
- Antipodes Partners fully exited Amazon in Q4 2022, selling an estimated $87.6M.
- Antipodes Partners's ten largest holdings make up 48% of its $2.79B portfolio in Q4 2022.
- Antipodes Partners opened 28 new positions and closed 3 in Q4 2022.
- Antipodes Partners's portfolio value rose 12% quarter-over-quarter to $2.79B.
Based on Antipodes Partners's 13F filing for Q4 2022, filed 8 Feb 2023.